Skip to main content

Affordability of Insulin for Non-Elderly Adults in the United States following $35 Monthly Out-of-Pocket Cap

This is a preview of subscription content, access via your institution.

References

  1. Bakkila BF, Basu S, Lipska KJ. Catastrophic Spending On Insulin In The United States, 2017-18. Health Aff . 2022;41(7):1053-1060.

    Article  Google Scholar 

  2. Sayed BA, Finegold K, Anders Olsen T, et al. Insulin Affordability and the Inflation Reduction Act: Medicare Beneficiary Savings by State and Demographics. ASPE Office of Health Policy. Published January 24, 2023. Accessed March 21, 2023. https://aspe.hhs.gov/sites/default/files/documents/bd5568fa0e8a59c2225b2e0b93d5ae5b/aspe-insulin-affordibility-datapoint.pdf

  3. Glied S, Zhu B. Not So Sweet: Insulin Affordability over Time. Commonwealth Fund Issue Brief, September. Published September 2020. Accessed March 21, 2023. https://www.commonwealthfund.org/sites/default/files/2020-09/Glied_not_so_sweet_insulin_affordability_ib.pdf.

  4. Hopkins JS. Diabetes Drug Giant Sanofi Cuts Insulin Prices by Up to 78%. WSJ Online. Published March 16, 2023. Accessed March 21, 2023. https://www.wsj.com/articles/diabetes-drug-giant-sanofi-cuts-insulin-prices-by-up-to-78-e9d7ada3

  5. Li M, Yuan J, Lu K. Estimates of Insulin Out-of-Pocket Cap-Associated Prescription Satisfaction, Adherence, and Affordability Among Medicare Beneficiaries. JAMA Netw Open. 2023;6(1):e2251208.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Peng I, Court E. Insulin Price Cuts Could End Up Making Money for US Drugmakers. Bloomberg News. https://www.bloomberg.com/news/articles/2023-03-14/slashing-insulin-prices-could-make-money-for-lilly-novo-nordisk. Published March 14, 2023. Accessed March 21, 2023.

  7. State Insulin Copay Caps. American Diabetes Association. Accessed March 21, 2023. https://diabetes.org/tools-support/insulin-affordability/state-insulin-copay-caps

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Andrew Sumarsono MD, MPH.

Ethics declarations

Conflict of Interest

The authors do not have any conflicts of interest for this article.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ghoreshi, K., Lokesh, N., Patel, L. et al. Affordability of Insulin for Non-Elderly Adults in the United States following $35 Monthly Out-of-Pocket Cap. J GEN INTERN MED (2023). https://doi.org/10.1007/s11606-023-08524-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s11606-023-08524-6